INDUSTRY HEALTH. TECH

framework that accelerates safe adoption, protects patients and commands public and professional confidence. I am so grateful to the many people who contributed to this expert commission to set out the roadmap ahead.”

The independent commission was established by the MHRA in September 2025 and includes diverse expertise across health, regulation and AI, including international contributors from around the world including the US and Singapore. he National Commission into the

Regulation of AI in Healthcare has published its recommendations on how the UK can strengthen the regulation of AI in healthcare, so it remains safe, keeps pace with innovation and continues to earn people’ s trust.

AI is already used in the NHS to spot serious health problems early, for example, strokes and skin cancers, and to free up clinicians’ time through voice-enabled technologies. The commission’ s recommendations aim to help many more patients benefit safely and quickly, by supporting the UK to become the best place for innovators to build and safely test AI, the best place for healthcare professionals to use it and most importantly, the best place for patients to engage with it in their care.

In launching this report, Professors Alastair Denniston and Henrietta Hughes, both practising NHS doctors, said:“ The National

Commission into the Regulation of AI in Healthcare is about defining what we want our future AI-enabled healthcare system to look like and how we use regulation to shape that future. This is about creating a future healthcare system that is increasingly techenabled and always people-centred.”

Lawrence Tallon, the Medicines and Healthcare products Regulatory Agency’ s( MHRA) Chief Executive, said:“ I welcome this authoritative and independent report which sets out in more detail than ever before how we should best regulate AI in healthcare.

“ We have heard clearly about the opportunities of AI to speed up and improve care and to release more of clinicians’ time for the essentially human aspects of their work with patients.

“ We will only realise those opportunities if we have a modern, dynamic regulatory

The commission gathered evidence from more than 12,000 people over the course of a year, including patients, the public, clinicians, healthcare leaders, industry and technology developers, making it the largest engagement of its kind ever undertaken in the UK on the regulation of healthcare technology. Additional in-depth deliberative research was carried out by research partner, the Health Foundation, with members of the UK public providing detailed insight into the UK public’ s priorities and expectations for the regulation of AI in healthcare.

This is about creating a future healthcare system that is increasingly tech-enabled and always people-centred.

Taken together, that engagement found broad public support for AI in healthcare, with clear conditions: strong safety standards, meaningful human oversight and transparency about when and how AI is being used in someone’ s care. The Commission’ s recommendations respond directly to these views.

42 WWW. INTELLIGENTCISO. COM